ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
ExcelFemale
HRT in Women
Testosterone and DHEA in Women- Effect on Sexual Function
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="Nelson Vergel" data-source="post: 34632" data-attributes="member: 3"><p><strong>Androgens and Female Sexual Function and Dysfunction—Findings From the Fourth International Consultation of Sexual Medicine</strong></p><p></p><p>The literature supports an important role for androgens in female sexual function. There is no blood androgen level below which women can be classified as having androgen deficiency. Clinical trials have consistently demonstrated that transdermal testosterone (T) therapy improves sexual function and sexual satisfaction in women who have been assessed as having hypoactive sexual desire disorder. The use of T therapy is limited by the lack of approved formulations for women and long-term safety data. Most studies do not support the use of systemic dehydroepiandrosterone therapy for the treatment of FSD in women with normally functioning adrenals or adrenal insufficiency. Studies evaluating the efficacy and safety of vaginal testosterone and dehydroepiandrosterone for the treatment of vulvovaginal atrophy are ongoing.<strong></strong></p><p><strong></strong></p><p><strong>Article Outline</strong></p><p></p><p><a href="http://www.jsm.jsexmed.org/article/S1743-6095(16)00076-X/fulltext#sec1" target="_blank">Introduction</a></p><p><a href="http://www.jsm.jsexmed.org/article/S1743-6095(16)00076-X/fulltext#sec2" target="_blank">Methods</a></p><p><a href="http://www.jsm.jsexmed.org/article/S1743-6095(16)00076-X/fulltext#sec3" target="_blank">Overview of Androgen Physiology in Women</a></p><p><a href="http://www.jsm.jsexmed.org/article/S1743-6095(16)00076-X/fulltext#sec4" target="_blank">Sex Steroid Measurements: Problems of Quality Control, Accuracy, and Sensitivity for T Assays</a></p><p><a href="http://www.jsm.jsexmed.org/article/S1743-6095(16)00076-X/fulltext#sec5" target="_blank">Evidence From Observational Studies That T and Other Androgens Play an Important Role in Human FSD (Level 2 Evidence)</a></p><p><a href="http://www.jsm.jsexmed.org/article/S1743-6095(16)00076-X/fulltext#sec6" target="_blank">Studies to Elucidate the Role of T in Female Sexual Function (Level 2 Evidence)</a></p><p><a href="http://www.jsm.jsexmed.org/article/S1743-6095(16)00076-X/fulltext#sec7" target="_blank">Evidence of T Effects From Clinical Trials of Systemic T Therapy</a></p><p><a href="http://www.jsm.jsexmed.org/article/S1743-6095(16)00076-X/fulltext#sec7.1" target="_blank">Clinical Trials of Naturally and Surgically Postmenopausal Women (Level 1 Evidence)</a></p><p><a href="http://www.jsm.jsexmed.org/article/S1743-6095(16)00076-X/fulltext#sec7.2" target="_blank">Clinical Trials of T Therapy in Women Taking Antidepressant Therapy (Level 1 Evidence)</a></p><p><a href="http://www.jsm.jsexmed.org/article/S1743-6095(16)00076-X/fulltext#sec8" target="_blank">Evidence From Studies of Women With POF/POI (Level 2 and 3 Evidence)</a></p><p><a href="http://www.jsm.jsexmed.org/article/S1743-6095(16)00076-X/fulltext#sec9" target="_blank">Recommendations</a></p><p><a href="http://www.jsm.jsexmed.org/article/S1743-6095(16)00076-X/fulltext#sec10" target="_blank">Evidence of Benefits of Topical Vaginal T (Level 2 and 3 Evidence):</a></p><p><a href="http://www.jsm.jsexmed.org/article/S1743-6095(16)00076-X/fulltext#sec11" target="_blank">Use of DHEA for Treatment of FSD</a></p><p><a href="http://www.jsm.jsexmed.org/article/S1743-6095(16)00076-X/fulltext#sec11.1" target="_blank">Evidence of Effects From Clinical Trials of Systemic DHEA Therapy (Level 1 Evidence)</a></p><p><a href="http://www.jsm.jsexmed.org/article/S1743-6095(16)00076-X/fulltext#sec12" target="_blank">Recommendation</a></p><p><a href="http://www.jsm.jsexmed.org/article/S1743-6095(16)00076-X/fulltext#sec12.1" target="_blank">Evidence of Benefits of Topical Vaginal DHEA (Level 2 Evidence):</a></p><p><a href="http://www.jsm.jsexmed.org/article/S1743-6095(16)00076-X/fulltext#sec13" target="_blank">Recommendation</a></p><p><a href="http://www.jsm.jsexmed.org/article/S1743-6095(16)00076-X/fulltext#sec14" target="_blank">Conclusions</a></p><p><a href="http://www.jsm.jsexmed.org/article/S1743-6095(16)00076-X/fulltext#cebib0010" target="_blank">References</a></p></blockquote><p></p>
[QUOTE="Nelson Vergel, post: 34632, member: 3"] [B]Androgens and Female Sexual Function and Dysfunction—Findings From the Fourth International Consultation of Sexual Medicine[/B] The literature supports an important role for androgens in female sexual function. There is no blood androgen level below which women can be classified as having androgen deficiency. Clinical trials have consistently demonstrated that transdermal testosterone (T) therapy improves sexual function and sexual satisfaction in women who have been assessed as having hypoactive sexual desire disorder. The use of T therapy is limited by the lack of approved formulations for women and long-term safety data. Most studies do not support the use of systemic dehydroepiandrosterone therapy for the treatment of FSD in women with normally functioning adrenals or adrenal insufficiency. Studies evaluating the efficacy and safety of vaginal testosterone and dehydroepiandrosterone for the treatment of vulvovaginal atrophy are ongoing.[B] Article Outline[/B] [URL="http://www.jsm.jsexmed.org/article/S1743-6095(16)00076-X/fulltext#sec1"]Introduction[/URL] [URL="http://www.jsm.jsexmed.org/article/S1743-6095(16)00076-X/fulltext#sec2"]Methods[/URL] [URL="http://www.jsm.jsexmed.org/article/S1743-6095(16)00076-X/fulltext#sec3"]Overview of Androgen Physiology in Women[/URL] [URL="http://www.jsm.jsexmed.org/article/S1743-6095(16)00076-X/fulltext#sec4"]Sex Steroid Measurements: Problems of Quality Control, Accuracy, and Sensitivity for T Assays[/URL] [URL="http://www.jsm.jsexmed.org/article/S1743-6095(16)00076-X/fulltext#sec5"]Evidence From Observational Studies That T and Other Androgens Play an Important Role in Human FSD (Level 2 Evidence)[/URL] [URL="http://www.jsm.jsexmed.org/article/S1743-6095(16)00076-X/fulltext#sec6"]Studies to Elucidate the Role of T in Female Sexual Function (Level 2 Evidence)[/URL] [URL="http://www.jsm.jsexmed.org/article/S1743-6095(16)00076-X/fulltext#sec7"]Evidence of T Effects From Clinical Trials of Systemic T Therapy[/URL] [URL="http://www.jsm.jsexmed.org/article/S1743-6095(16)00076-X/fulltext#sec7.1"]Clinical Trials of Naturally and Surgically Postmenopausal Women (Level 1 Evidence)[/URL] [URL="http://www.jsm.jsexmed.org/article/S1743-6095(16)00076-X/fulltext#sec7.2"]Clinical Trials of T Therapy in Women Taking Antidepressant Therapy (Level 1 Evidence)[/URL] [URL="http://www.jsm.jsexmed.org/article/S1743-6095(16)00076-X/fulltext#sec8"]Evidence From Studies of Women With POF/POI (Level 2 and 3 Evidence)[/URL] [URL="http://www.jsm.jsexmed.org/article/S1743-6095(16)00076-X/fulltext#sec9"]Recommendations[/URL] [URL="http://www.jsm.jsexmed.org/article/S1743-6095(16)00076-X/fulltext#sec10"]Evidence of Benefits of Topical Vaginal T (Level 2 and 3 Evidence):[/URL] [URL="http://www.jsm.jsexmed.org/article/S1743-6095(16)00076-X/fulltext#sec11"]Use of DHEA for Treatment of FSD[/URL] [URL="http://www.jsm.jsexmed.org/article/S1743-6095(16)00076-X/fulltext#sec11.1"]Evidence of Effects From Clinical Trials of Systemic DHEA Therapy (Level 1 Evidence)[/URL] [URL="http://www.jsm.jsexmed.org/article/S1743-6095(16)00076-X/fulltext#sec12"]Recommendation[/URL] [URL="http://www.jsm.jsexmed.org/article/S1743-6095(16)00076-X/fulltext#sec12.1"]Evidence of Benefits of Topical Vaginal DHEA (Level 2 Evidence):[/URL] [URL="http://www.jsm.jsexmed.org/article/S1743-6095(16)00076-X/fulltext#sec13"]Recommendation[/URL] [URL="http://www.jsm.jsexmed.org/article/S1743-6095(16)00076-X/fulltext#sec14"]Conclusions[/URL] [URL="http://www.jsm.jsexmed.org/article/S1743-6095(16)00076-X/fulltext#cebib0010"]References[/URL] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
ExcelFemale
HRT in Women
Testosterone and DHEA in Women- Effect on Sexual Function
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top